Sorin Group S.p.A. Announces the First U.S. Clinical Implant of the World’s Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator - OVATIO(TM) CRT

DENVER, Colo.--(BUSINESS WIRE)--ELA Medical, Inc, a Sorin Group company (MIL:SRN), announced today the first U.S. implant in the Investigational Trial of the OVATIO™ CRT, Cardiac Resynchronization Therapy Defibrillator, Model 6750. The first clinical implant of OVATIO™ CRT-D, the smallest biventricular ICD currently available outside the U.S. at 30cc, was successfully performed by Dr. Eli S. Gang, Clinical Professor of Medicine, David Geffen School of Medicine, UCLA. The implant occurred at Brotman Medical Center, Culver City, California.

MORE ON THIS TOPIC